Your browser doesn't support javascript.
loading
Why a randomized melanoma screening trial may be a good idea.
Cust, A E; Aitken, J F; Baade, P D; Whiteman, D C; Soyer, H P; Janda, M.
Affiliation
  • Cust AE; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia.
  • Aitken JF; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Baade PD; Cancer Council Queensland, Brisbane, Australia.
  • Whiteman DC; Menzies Health Institute, Griffith University, Southport, QLD, Australia.
  • Soyer HP; Cancer Council Queensland, Brisbane, Australia.
  • Janda M; School of Mathematical Sciences, Queensland University of Technology, Brisbane, Australia.
Br J Dermatol ; 179(5): 1227-1228, 2018 11.
Article in En | MEDLINE | ID: mdl-30101459
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Diagnostic_studies / Screening_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Diagnostic_studies / Screening_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2018 Document type: Article Affiliation country: Country of publication: